Giannoula Klement

MicroCT scanner performance and considerations for vascular specimen imaging.

R Mark Henkelman, Michael Marxen, John G Sled, 2004, Medical physics.

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Peter Bohlen, Robert S. Kerbel, S. Baruchel, 2000 .

Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease

Gil Alterovitz, Xiao-Ying Meng, Rainer Haas, 2007, Proceedings of the National Academy of Sciences.

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.

Barbara Mayer, Peter Bohlen, Shane K Green, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Serum Protein Profiling with Mass Spectrometry for the Diagnosis of Myelodysplastic Syndromes.

Gil Alterovitz, Xiao-Ying Meng, Hasan H. Otu, 2004 .